Answers are grounded in this paper and cite their sources.
MS Binding Assays for the orthosteric binding site of Tetronarce californica nicotinic acetylcholine receptor (nAChR) as an alternative to radioligand binding assays are presented. As a reporter ligand, at first, rac ‐epibatidine was employed, as in radioligand binding assays often using rac ‐[ 3 H]epibatidine. For the quantification of rac ‐epibatidine in the binding samples, a fast and highly sensitive LC‐ESI‐MS/MS method has been developed. This method was finally used in saturation experiments with rac ‐epibatidine but also with its (+)‐ and (−)‐enantiomers as MS markers. Based on (−)‐epibatidine as the most affine ligand of these three compounds, also competitive MS Binding Assays have been established and used for the characterization of the binding affinity of a set of reference compounds. The affinities obtained with these new MS Binding Assays are in good accordance with those reported from radioligand binding experiments. This demonstrates that the new MS Binding Assays, in particular with (−)‐epibatidineas MS marker, represent a valuable and powerful alternative to radioligand binding assays frequently used so far for this purpose. Furthermore, the feasibility of simultaneous MS Binding Assays, in which (−)‐epibatidine and BTCP address the orthosteric and the ion channel binding site of the nAChR, respectively, in the same saturation experiment, has been demonstrated.
No takes yet. Share an insight, caveat, or question.
Währa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: